Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Scalp micro-wounding helps promote hair growth in female pattern hair loss.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Umbilical cord-derived media is safe and effective for hair growth.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Microneedling helps with hair loss, especially with 5% minoxidil, but more high-quality research is needed.

Higher bad cholesterol levels are linked to more severe female pattern hair loss.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

New scale reliably assesses male hair loss with female pattern.

Low quality of life and high HSS-29 scores increase risk of losing patients during treatment.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

The Sinclair Shedding Scale is effective for diagnosing Alopecia Areata Incognita and monitoring treatment success.

Antioxidant-rich diets may reduce hair loss risk, while pro-inflammatory diets may increase it, especially in women.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Older age and certain lifestyles are linked to thinner, weaker hair, while how you see your hair relates to its thickness.

The new visual scale is a quick and effective way to measure hair loss in women.

The conclusion is that there's no significant link between male pattern baldness and the severity of coronary artery disease.

JetPeel-assisted minoxidil improves hair density and thickness more than minoxidil alone.

The Spanish Hair-Specific Skindex-29 questionnaire effectively measures the quality of life impact of hair loss in Spanish-speaking women.

Finasteride may cause slight depression and anxiety.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.